| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5510353 | ALFASIGMA | Certain aminoguanidine compounds, pharmaceutical compositions containing them and their use in treating gastrointestinal motility disorders and disorders associated with cephalic pain |
Apr, 2013
(11 years ago) | |
Zelnorm is owned by Alfasigma.
Zelnorm contains Tegaserod Maleate.
Zelnorm has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Zelnorm are:
- US5510353
Zelnorm was authorised for market use on 24 July, 2002.
Zelnorm is available in tablet;oral dosage forms.
Zelnorm can be used as treatment of irritable bowel syndrome.
The generics of Zelnorm are possible to be released after 26 April, 2013.
Drugs and Companies using TEGASEROD MALEATE ingredient
Market Authorisation Date: 24 July, 2002
Treatment: Treatment of irritable bowel syndrome
Dosage: TABLET;ORAL
More Information on Dosage
ZELNORM family patents
